活性成分Active Ingredient

Eran Ji (二氨基)二氨基

This is an ingredient/substance record as used in registered products or formulas.本页为注册药品或方剂中使用的成分/物质记录。

What we know已知信息

Recorded name (CN)已记录名称: 二氨基
Record kind: ingredient/substance as used in registered products or formulas记录类型：注册药品或方剂中使用的成分/物质
Registered medicines on this record本页已记录的注册药品数: 43
Recorded product types已记录产品类型数: 11
Recorded dosage forms已记录剂型数: 5
Manufacturers on recorded products已记录生产企业数: 37
Product links on this page本页药品链接数: 16

No product-level labeled indications/safety are joined for this record.本记录未接入产品级适应症/安全性标注字段。

在药品知识图谱中有 43 条已注册药品记录。43 registered medicine records in MedicineGraph.

43

注册药品Registered medicines

11

产品类型Product types

5

剂型Dosage forms

37

生产企业Manufacturers

产品类型分布Product Type Distribution

妥布霉素滴眼液滴眼剂

28 条记录records (65.1%) . 27 家企业companies

利必通片剂

3 条记录records (7.0%) . 1 家企业companies

关联药品（名称待核验）未标注

3 条记录records (7.0%) . 0 家企业companies

马来酸伊索拉定片片剂

2 条记录records (4.7%) . 2 家企业companies

科玛诺片剂

1 条记录records (2.3%) . 1 家企业companies

佳诺泰滴眼剂

1 条记录records (2.3%) . 1 家企业companies

恒至片剂

1 条记录records (2.3%) . 1 家企业companies

注射用硫酸妥布霉素注射剂

1 条记录records (2.3%) . 1 家企业companies

硫酸新霉素软膏乳膏剂

1 条记录records (2.3%) . 1 家企业companies

盖世龙片剂

1 条记录records (2.3%) . 1 家企业companies

剂型分布Dosage Form Distribution

滴眼剂

29 (67.4%)

片剂

9 (20.9%)

未标注

3 (7.0%)

注射剂

1 (2.3%)

乳膏剂

1 (2.3%)

主要生产企业Top Manufacturing Companies

(澳大利亚)Chinese legal name: (澳大利亚)

3 条相关记录related records

辰欣药业股份有限公司Chinese legal name: 辰欣药业股份有限公司

2 条相关记录related records

宁夏康亚药业有限公司Chinese legal name: 宁夏康亚药业有限公司

1 条相关记录related records

合肥利民制药有限公司Chinese legal name: 合肥利民制药有限公司

1 条相关记录related records

武汉五景药业有限公司Chinese legal name: 武汉五景药业有限公司

1 条相关记录related records

浙江万晟药业有限公司Chinese legal name: 浙江万晟药业有限公司

1 条相关记录related records

南京恒生制药有限公司Chinese legal name: 南京恒生制药有限公司

1 条相关记录related records

杭州国光药业有限公司Chinese legal name: 杭州国光药业有限公司

1 条相关记录related records

河北医科大学制药厂Chinese legal name: 河北医科大学制药厂

1 条相关记录related records

赛诺菲 (杭州)制药有限公司Chinese legal name: 赛诺菲 (杭州)制药有限公司

1 条相关记录related records

代表性产品Representative Products

妥布霉素滴眼液Recorded Chinese product: 妥布霉素滴眼液

宁夏康亚药业有限公司 | 5ml:15mg(1.5万单位) | Registration: 国药准字H20063994

妥布霉素滴眼液Recorded Chinese product: 妥布霉素滴眼液

合肥利民制药有限公司 | 5ml:15mg | Registration: 国药准字H20067215

妥布霉素滴眼液Recorded Chinese product: 妥布霉素滴眼液

辰欣药业股份有限公司 | 8ml：24mg（2.4万单位） | Registration: 国药准字H20063553

妥布霉素滴眼液Recorded Chinese product: 妥布霉素滴眼液

武汉五景药业有限公司 | 5ml:15mg(1.5万单位) | Registration: 国药准字H20054686

妥布霉素滴眼液Recorded Chinese product: 妥布霉素滴眼液

杭州国光药业有限公司 | 5ml:15mg | Registration: 国药准字H20054404

妥布霉素滴眼液Recorded Chinese product: 妥布霉素滴眼液

河北医科大学制药厂 | 8ml:24mg(2.4万单位) | Registration: 国药准字H20063913

妥布霉素滴眼液Recorded Chinese product: 妥布霉素滴眼液

湖北远大天天明制药有限公司 | 0.3% | Registration: 国药准字H20065831

妥布霉素滴眼液Recorded Chinese product: 妥布霉素滴眼液

沈阳圣元药业有限公司 | 5ml:15mg | Registration: 国药准字H20066185

数据局限性Data Limitations

药品知识图谱不提供适应症、用法用量、禁忌症或用药建议。MedicineGraph does not provide indications, dosage, contraindications, or medication advice.
数据来自药品注册数据库，不代表完整目录。Data comes from medicine registration databases. This is not a complete catalog.

关于数据质量About Data Quality

Total records: 43

Band: 26-50

Mode: LIMITED_KNOWLEDGE_PAGE

Product families: 11

Name resolution: 10/43

Generated: 2026-08-20

Version: Phase 30.7 V3 Adaptive Full Family

这是什么What is this

名称Name: 二氨基
实体类型Entity type: 活性成分Active ingredient

本段仅展示图谱已记录的身份信息，不含适应症、用法或疗效主张。Identity from recorded graph fields only; no indications, dosing, or efficacy claims.

含该成分的药品（已记录）Products containing this ingredient

妥布霉素滴眼液Recorded Chinese product: 妥布霉素滴眼液

关联实体Relationships

信息来源与范围Source and scope

MedicineGraph 已记录实体与精确关系；非完整目录。不推断未记录的临床属性。MedicineGraph recorded entities and exact relationships only; not a complete catalog. No inferred clinical attributes.

信息来源Source and scope

国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.